Objectives: Arthritis with intra-articular inflammation was accompanied by joint pain, swelling, and stiffness leading to significant functional impairment. Thus, regulation of joint inflammation is a good therapeutic approach for patients with arthritis. In this study, the effect of low intensity ultrasound (LIUS) applied to an adjuvant-induced arthritic rat model on the synovium was investigated. Design: Synovial inflammation was induced by complete Freund's adjuvant (CFA)-injection into the rat knee joint. LIUS (200 mW/cm 2 ) was applied on the ipsilateral knee everyday for 10 min beginning 1 day after inflammation induction. The expression of proinflammatory factors and immunohistochemical staining pattern of the synovium were assessed. Results: CFA induced an increase of the knee circumference that was significantly diminished by LIUS. Synovial membrane hyperplasia in the ipsilateral joint was also affected by LIUS. The inflammatory mediators, COX-1/2, IL-1b, and iNOS, but not TNF-a, in the synovial membrane were induced after 3 days, and they closely correlated with the degree of edema. In the synovial membrane, the expression of inflammatory mediators was reduced by LIUS. The chemoattractant chemokine receptor CCR5 also was involved. On immunohistochemical analysis, CFA caused increased infiltration of CD11b-positive cells in the synovium. After 3 days, neutrophils, myeloperoxidase (MPO)-positive cells filled the inflammatory core; later, monocytes and macrophages, ionized calcium binding adaptor molecule 1 (Iba1)-positive cells in the periphery infiltrated the core by day 5. LIUS markedly reduced CFA-induced inflammatory cells infiltration. Conclusion: LIUS showed a potent anti-inflammatory effect in this animal arthritis model with reduced infiltration of inflammatory cells into the synovium.
Introduction
Arthritis is characterized by joint inflammation, which includes immune cell infiltration, synovial hyperplasia, pain, and swelling 1 . The immune cell infiltrate plays an important role in the inflammatory process. First, inflamed tissue releases proinflammatory molecules such as cytokines and prostaglandins (PGs) that act as warning signals. These molecules promote leukocyte infiltration into the inflamed tissue through enhanced expression of chemokines and adhesion molecules. The inflammatory cells then produce inflammatory mediators such as interleukins (ILs), tumor necrosis factor alpha (TNF-a), nitric oxide (NO), and prostaglandins E 2 (PGE 2 ), which further aggravate synovial inflammation. PGE 2 is a well-known inflammatory mediator that modulates pain and immune processes 2, 3 . It is produced by cyclooxygenase (COX) in inflamed tissue. COX-2 is assumed to increase in inflammatory joint disease including osteoarthritis (OA) and rheumatoid arthritis (RA) 4e6 . COX-2 modulates inflammatory responses including chemokine release, adhesion molecule expression, plasma and cell exudation, cytokine release and cellular proliferation 7 ; thus COX-2 comprises all the feature of inflammation. Nonsteroidal antiinflammatory drugs (NSAIDs) target COX and inhibit PGE 2 production. They are considered first-line treatment for reduction of pain and stiffness in arthritis 8, 9 . However, side effects of NSAIDs include gastric ulcer and cardiotoxicity. Thus more effective therapeutic ways with fewer side effects are needed.
In the adjuvant-induced mono-arthritis (AIA) model 10, 11 , complete Freund's adjuvant (CFA) heat-killed Mycobacterium butyricum or Mycobacterium tuberculosum has been injected into the intra-articular space of the knee joint. Edema and pain are produced within 12 h; cartilage destruction and bone erosion may persist for several weeks 12 . In this arthritic model, higher level of PGE 2 (an index of COX-2 activity), thromboxane B 2 (an index of COX-1 activity), and proinflammatory cytokines TNF-a, IL-1b, and IL-6 are seen in the serum and synovial fluid 13 . Cytokine expression in the inflamed synovial membrane of arthritis leads to formation of osteoclasts 14 . These cells are primarily involved in the resorption of mineralled cartilage and bone. Therefore, synovitis is not considered as an incidental finding of OA, but plays a significant role in disease pathogenesis, and can therefore represent a target for future treatment 15 .
Low intensity ultrasound (LIUS), an alternative source of mechanical signals, has proven useful in many diseases, particularly in soft tissues disease involving cartilage or intervertebral disc 16, 17 . Recent studies report that LIUS is useful in promoting bone fracture healing and tendon repair, and reducing postoperative pain and swelling 18 . LIUS can be easily applied to targeted joints as local physiotherapy 18 . In human OA patient, LIUS reduces joint pain scores and also has chondroprotection 19 , which is observed in various animal arthritic models 20e22 . LIUS regulates chondrocytes and cartilage metabolism. In other reports LIUS was used for NSAID phonophoresis to increase intradermal transport 23 and uptake of hyaluronan into the synovium in OA 20 . Previously, we report that LIUS can help reducing the joint edema with reduction of PGE 2 in the synovial fluid of surgical rabbit OA model. Despite these promising findings, the effects of LIUS alone on the biological activity of cytokines, COX enzymes and inflammation in arthritic synovium have not been elucidated. Therefore, we hypothesized that LIUS would affect arthritic synovium and might regulate proinflammatory cytokines, COXs, iNOS and infiltration of immune cells and subsequently affect AIA-induced arthritis.
Materials and methods

Induction of arthritis and ultrasound exposure
Inflammatory arthritis was induced in male Sparague-Dawley rats (220e230 g; Samtako, Osan, Korea) with a modified method described previously 24 . Briefly, rats were anesthetized with pentobarbital (60 mg/kg, Hanlim Pharm. Co., Seoul, Korea), and 150 mg of CFA (1 mg/ml, Sigma, St. Louis, MO, USA) was injected into the intra-articular space of the left knee joint. A sham-control group was injected with 150 ml of saline. In the LIUS-treated group (post-US), LIUS was applied on the ipsilateral left knee 1 day after induction of arthritis. The ultrasound was applied by the therapeutic ultrasonic system (HNT medical, Seoul, Korea). LIUS was generated in a continuous-wave mode at a frequency of 1 MHz and intensity of 30, 100 and 200 mW/cm 2 . LIUS was applied for 10 min everyday for 5 days.
Measurement of the knee circumference
To assess edema of the arthritic knee joint, rats were fixed with an acryl holder and the knee circumference of each rat was measured using a flexible tape measure. Eleven or 12 rats for each group were examined (Sham; n ¼ 11, CFA; n ¼ 12, post-US; n ¼ 12) and the ipsilateral knee circumferences were measured once in everyday. The measurements were conducted for 5 days after inflammation induction.
Synovial membrane preparation
At 3 and 5 days after CFA injection, rats were anesthetized with pentobarbital and transcardially perfused with steady flow (45 ml/min, 3 min) of 0.9% saline to remove blood from the tissue. Then, the synovial membranes were collected from the knee joint and immediately homogenized for mRNA extraction or stored at À72 C until used.
RNA isolation and semi-quantitative RT-PCR
To isolate total RNA, 3 days after CFA injection, synovial tissues from seven rats for each group were collected and homogenized in 1 ml of Easy-Blue kit (Intron, Seongnam, Korea). Quality and purity of the isolated RNA was checked by ND-1000 UV/Vis spectrophotometer (NanoDrop Ò , Wilmington, DE, USA). One microgram of total RNA was reverse transcribed to prepare cDNA using 0.5 mU AMV reverse transcriptase (Roche, Indianapolis, IN, USA). PCR was performed using 1 ml of cDNA from each sample. A TAKARA perfect shot (TAKARA, Otsu, Japan) was used with a reaction mixture containing 50 mM KCl, 10 mM TriseHCl (pH 9.0), 0.1% Triton X-100, 0.5 mM MgCl 2 , 200 mM dNTPs, 0.1 U/ml of Ex TaqÔ DNA polymerase and 1 mM each of forward and reverse primer. TNF-a and IL-1b primer sequences were previously reported 25 . Table I described the oligonucleotide primers.
Western blot analysis
Synovial tissues were collected at third (n ¼ 9 for each group) and fifth (n ¼ 12 for each group) day after CFA injection and homogenized in homogenizing buffer [50 mM TriseCl (pH 7.4), 150 mM NaCl, 1% triton X-100, 0.1% sodium dodecyl sulfate (SDS), 1 mM MgCl 2 and 0.5% sodium deoxychlorate] supplemented with protein inhibitors. The supernatant was collected after centrifugation at 14,000 rpm for 15 min at 4 C and its protein concentration was then determined by BCA reagent (Thermo, Rockfore, IL, USA). Fifty microgram of each protein sample was denatured by boiling in 4Â laemli buffer [51.25 mM TriseCl (pH 6.8), 10% glycerol, 2.5% SDS, and 5% mercaptoethanol] and separated on a 10% SDS polyacrylamide gel. For immunoblotting, the proteins were transferred onto a polyvinylidene fluoride membrane (PVDF, Millipore, Bedford, MA, USA) with a semi-dry transfer cell (BIO-RAD, Hercules, CA, USA). The membranes were blocked 1 h in 20 mM TriseHCl (pH 7.6), containing 0.8% NaCl, 0.1% Tween20 (TBS-T) and 5% skim milk. Then membranes were incubated with antibodies against COX-1 (1:500, Cayman, Ann Arbor, MI, USA), COX-2 (1:500, Cayman), TGCATGTGGCTGTGGATGTCATCAA  583  Reverse  CACTAAGACAGACCCGTCATCTCCA  COX-2  Forward  ACTCACTCAGTTTGTTGAGTCATTC  450  Reverse  TTTGATTAGTACTGTAGGGTTAATG  TNF-a  Forward  GACCCTCACACTCAGATCAT  210  Reverse  TTGAAGAGAACCTGGGAGTA  IL-1b  Forward  GCAACTGTTCCTGAACTC  382  Reverse  CTCGGAGCCTGTAGTGCA  CCR5  Forward  TTGCCCTGAGAAGAAAGGATG  336  Reverse  ACAAAACTGTCTAGGTGCTCC  GAPDH  Forward  GTGAAGGTCGGTGTGAACGGATTT  553  Reverse  CACAGTCTTCTGACTGGCAGTGAT with TBS-T, it was incubated with goat anti-rabbit horse-radish peroxidase-conjugated secondary antibody (1:30,000, Jackson Immunoresearch, Baltimore, PA, USA). For the quantification of the chemiluminescent signals, PVDF membranes were scanned with a Fuji Film LAS-1000 system and analyzed using Multi Gauge software (version 3.0).
Immunohistochemistry
The rats were anesthetized with sodium pentobarbital and perfused transcardially with saline followed by 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS). The synovium from the knee joint was removed immediately and post-fixed overnight in 4% PFA and then cryoprotected with 30% sucrose in PBS for 48 h. Each synovium was cut in 20 mm thick by a cryostat-microtome CM1900 (LEICA, Houston, TX, USA). The sectioned synovial tissue was quenched with 0.3% H 2 O 2 in PBS and then blocked with 5% normal goat serum in PBS for 2 h. Later, blocked tissue was incubated with rabbit anti-COX-1 (1:300, Cayman), anti-COX-2 (1:200, Cayman), anti-CD11b (1:300, Abcam), anti-MPO (1:200, Dako, Glostrup, Denmark), and anti-Iba1 (1:300, Wako, Richmond, VA, USA) antibodies followed by secondary antibody labeled with Alexa Fluor 488 (1:300, Invitrogen, Eugene, OR, USA). Nuclei were stained by Hoechst33258 and the tissue was mounted with VECTASHIELD (Vector Lab, Burlingame, CA, USA). Images were acquired with a Zeiss LSM 710 confocal microscope (Carl Zeiss, Jena, Germany).
Statistical analysis
The data are expressed as the mean AE 95% confidence interval. Comparison of ultrasound effect between different groups was done using one way analysis of variance (ANOVA) followed by the Tukey test. The Spearman correlation test was performed for correlation analysis in total animals including sham, inflammation and post-US group. All analyses were performed using the computer program SPSS 18.0 (SPSS Inc.) with a statistical significance of P < 0.05.
Results
Effect of LIUS on knee edema
The ipsilateral knee circumference in AIA rats began to increase within 24 h, and edema was maintained for 5 days. Treatment with LIUS for 10 min was applied everyday beginning 24 h after arthritis induction. Preliminary, we examined effect of various LIUS intensities, 30, 100 and 200 mW/cm 2 (n ¼ 5, each group) on knee edema. LIUS reduced the knee circumference in a dose-dependent manner. Five days after induction, the knee circumferences were reduced to 57.0 mm AE 2.48 (P ¼ 0.059 vs CFA group) in 30 mW/cm 2 , 56.4 mm AE 3.47 (P ¼ 0.017 vs CFA group) in 100 mW/cm 2 and 55 mm AE 1.23 (P < 0.001 vs CFA group) in 200 mW/cm 2 of LIUS, while to 51.4 mm AE 1.05 in sham-control group and 60.47 mm AE 1.55 in only CFA group. In Fig. 1 (n ¼ 12) , the effect of LIUS with 200 mW/cm 2 was shown. At 2 days after induction, knee edema was significantly attenuated in LIUS-treated (post-US) group compared with the untreated group (CFA). The difference between the untreated group (CFA) and treated group increased over time. At day 5, knee edema was reduced in the post-US group to that controls ( Fig. 1 ).
Effect of LIUS on inflammatory mediators
To evaluate the anti-inflammatory effect of LIUS stimulation on arthritic joint, gene and protein levels of the inflammatory mediators COX-1, COX-2, IL-1b, TNF-a and iNOS were measured in the synovium. COX-1, COX-2 and IL-1b genes were highly expressed in the inflammatory synovium 3 days after AIA induction; however TNF-a expression remained at the basal level. The administration of LIUS significantly reduced the levels of COX-2 (P ¼ 0.008) and IL-1b Fig. 2(A) ]. The decrease of COX-1 mRNA expression by LIUS was not statistically significant, however the expression of COX-2 and IL-1b was inhibited by LIUS and positively correlated with knee circumference. Specifically COX-2 (r ¼ 0.803, P < 0.001) showed very strong correlation [ Fig. 2(B) ].
Protein levels of inflammatory molecules were also analyzed in the synovium. AIA induction enhanced not only expression of COX-1, COX-2 and iNOS, the synthesizing enzymes for inflammatory mediators including PGs and NO, but also expression of CD11b, which is a widely used immune cell marker for neutrophils, basophils, monocytes and macrophage. Increased levels of these proteins were present on both day 3 [ Fig. 3(A) ] and day 5 [ Fig. 3(B) ]. Coincident with the reduction in edema, LIUS reduced expression of COX-1, COX-2, iNOS and CD11b [ Fig. 3(A and B) ]. On day 5 LIUS significantly decreased COX-2 (P ¼ 0.001) and iNOS (P ¼ 0.007), but not COX-1 (P ¼ 0.36). In contrast, on day 5, LIUS stimulation significantly decreased COX-1 (P ¼ 0.002), but not COX-2 (P ¼ 0.07) and iNOS (P ¼ 0.15). CD11b was significantly reduced by LIUS on both day 3 (P ¼ 0.04) and day 5 (P ¼ 0.01). To demonstrate that the anti-edema effect of LIUS was achieved through regulation of these inflammatory molecules, we analyzed the correlation between knee circumference and the relative expression levels of inflammatory molecules among three groups. Expression of inflammatory molecules including COX-1, COX-2, iNOS and CD11b showed a strong correlation with knee circumference (Table II) . This data suggests that the development of edema coincides with up-regulation of inflammatory mediators. The first step of the inflammatory process correlates with immune cell infiltration. The degree of immune cell infiltration is represented by CD11b expression. The expression of enzymes responsible for production of PGs and NO correlated strongly with expression of CD11b (Table III) on day 3. These data suggest that PGs and NO production is involved in immune cell infiltration. 
Effect of LIUS on chemokine receptor CCR5
Expression of CCR5, an important chemotactic factor in arthritis, was studied. To evaluate the effect of LIUS stimulation on chemotaxis into synovial tissue, the level of CCR5 gene in the synovium was measured. CCR5 was highly expressed in the inflammatory synovium 3 days after AIA induction, and administration of LIUS significantly reduced this expression (P ¼ 0.006) ( Fig. 4 ). Expression of CCR5 was inhibited by LIUS and positively correlated with knee circumference (r ¼ 0.626, P ¼ 0.004) ( Fig. 5 ).
Effect of LIUS on immune cells recruitment
We immunohistochemically examined leukocyte infiltration in arthritic synovium and the effect of LIUS on leukocyte migration. To define the infiltrating cells, myeloperoxidase (MPO) and ionized calcium binding adaptor molecule 1 (Iba1) antibody were used. The MPO-positive cells represent neutrophils and Iba1-positive cells represent monocytes and macrophages. In the CFA-induced arthritic synovium, the numbers of CD11b-positive cells were increased. All CD11b-positive cells also expressed COX-1 and COX-2 (data not shown). Generally, neutrophils are the first immune cell to infiltrate the site of inflammation, where they promote the release of inflammatory mediators and the chemotaxis of other immune cells. Macrophages are recruited after neutrophils infiltration. AIA induction profoundly increased neutrophil and macrophage infiltration in the synovium. On day 3, the arthritic synovium was swollen and filled with MPO-positive cells in the core surrounded by Iba1-positive cells. On day 5, the MPO-positive cells disappeared and the Iba1-positive cells populated the core. In LIUS-treated group, the MPO-positive core was not prominent and neutrophil infiltration was significantly decreased on day 3 compared to the non-treated group. Therefore, the antiinflammatory effect of LIUS might be due to decreased inflammatory cell infiltration.
Discussion
In the present study, AIA produced profound edema of the injected knee, increased expression of inflammatory mediator genes including COX-2, iNOS, IL-1b and CCR5, and promoted inflammatory cell infiltration in the synovium. LIUS induced reduction in knee swelling and inflammatory markers in the synovium apparently via a reduction in inflammatory cell infiltrate.
Ultrasound is used as an alternative treatment to conventional medical therapy. As discussed above, it has been applied in many different fields 16, 18, 22, 26 . The beneficial biological effects of ultrasound have been applied to tissue regeneration, cancer treatment, and immune and vascular stimulation 26 . In randomized, placebocontrolled, and double-blind study, LIUS can be efficacious for decreasing pain and may improve physical function in human knee OA 19, 27 . In animal OA model, LIUS increases the articular cartilage type II collagen, thereby exhibiting chondroprotective action 22 . Ultrasound induced in aggrecan gene expression and chondroitin sulfate synthesis in chondrocytes originated from rat 28 , rabbit 29 , and also human OA patient 30 . Specially, LUIS also prevents the spontaneous articular degeneration in guinea pig model, and reduced TGF-b1 production considered as acute repair response 21 . Therefore, the chondroprotective effect of LIUS is not determined by whether active repair or reduced cartilage degeneration. In our study, LUIS can modulate inflammatory process in the synovium, thereby the protective effect of LUIS on OA cartilages can be explained. Furthermore, regulation of synovial inflammation can be an important target for treatment of OA.
We demonstrated the protective effect of LIUS on CFA-induced edema with 0.2 W/cm 2 intensity, 1 MHz for every 5 days. In CFAinduced arthritis model, edema began several hours after injection and approached a peak 2e3 days, and began to subside after 5 days. Therefore, we treated LIUS after 1 day and then every 5 days. This ultrasonic energy can be divided into two categories: highintensity ultrasound with peak intensities from 5000 to 15,000 W/cm 2 , and LIUS with intensities of 0.5e3000 W/cm 2 17 . US is widely used as an imaging modality at intensity of . In the present study, LIUS against CFA-induced edema in rats has been shown from 0.03 W/cm 2 for 10 min 5 days after application, and LIUS with intensity of 0.2 W/cm 2 for 10 min re-showed reducing edema 1 day after application.
Proinflammatory cytokines, including IL-1b and TNF-a, play a key role in the regulation of inflammation. However, these two cytokines are thought to act independently in acute arthritis models. IL-1b is the most important cytokine in the pathogenic progress of arthritis. It induces the production of matrix metalloproteinase (MMP) and PGE 2 through increasing COX-2 expression 31, 32 . Kuiper et al. reported the differential kinetics of TNF-a and IL-1b production. In their experiments TNF-a peaked earlier than IL-1b, and was not involved in cell influx or proteoglycan metabolism 33 . IL-1b plays a dominant role in inflammatory cell infiltration and cartilage destruction, whereas TNF-a regulates joint swelling 33, 34 . In their model TNF-a was not involved in rigorous (green) were infiltrating the inflamed synovium on day 3 and disappeared on day 5. Iba1 þ macrophages/monocytes were located around the MPO core on day 3. Almost all cells of the MPO þ core were replaced by highly activated macrophages on day 5. LIUS attenuated neutrophil and macrophage infiltration on both day 3 and 5. Images were acquired with a Zeiss LSM 710 confocal microscope (Carl Zeiss). immune processes, a finding confirmed by our study. TNF-a is expressed in the lining of the synovial membrane at the time of arthritis onset; IL-1b is also detected but at a slightly later stage of the disease 35 . In our study, there was little change in TNFa expression on day 3, while IL-1b expression was increased.
However, the increased knee circumference correlated closely with IL-1b level and with COX expression, but not TNF-a.
COX-2 is induced and activated by inflammation to produce PGE 2 , which modulates pain, swelling and cytokine release. COX-2 is highly expressed in both OA and RA patients and in animal models 5, 36, 37 . PGE 2 promotes angiogenesis and arthritic tissue degradation via inhibition of collagen synthesis, increased MMP release, and enhanced chondrocyte apoptosis 38 . The other important inflammatory marker, iNOS, is induced by inflammatory stimuli. NO released from iNOS is a readily diffusible and highly reactive. NO exhibits both pro-and anti-inflammatory properties 39 . Our data revealed that both COX-2 and iNOS mRNA and protein level increased significantly on day 3 and day 5, in AIA synovium. The expression of COX-2 and iNOS was attenuated by LIUS treatment. As reported earlier, COX-2 inhibition is considered a primary therapeutic approach for relief of mild to moderate pain. In our study, COX-2 expression is highly correlated with knee edema. NSAIDs, which inhibit COX, are used clinically based on their antiinflammatory and analgesic properties. The first generation of NSAIDs inhibits both COX isoforms and carries a risk of gastric ulcer. Adverse gastrointestinal toxicity is attributed to the inhibition of gastroprotective PGs, which are mainly produced by the homeostatic COX-1 pathway 40 . Second generation NSAIDs, the selective COX-2 inhibitors such as celecoxib or rofecoxib, have the advantage of reduced gastrointestinal toxicity; however, cardiovascular toxicity has been reported with these drugs. Based on this data and results of our study, LIUS stimulation may represent an alternative treatment to reduce COX-2 and iNOS expression, especially in the early stage of arthritic joint.
Cellular infiltration is one pathologic process involved in arthritis; this includes an increase in tissue macrophages and abnormal hypertrophy of the synovial membrane 41 . In the arthritic synovial membrane, increased cellularity is obvious, which represents cellular migration from circulating blood 35 . In our model, CD11b-positive cells infiltrated the arthritic synovium and the potent chemotaxic chemokine receptor CCR5 was also increased. CCR5 is the natural receptor for the ligands CCL3 (macrophage inflammatory protein 1a, MIP-1a), CCL4 (MIP-1b), and CCL5 (RANTES), all of which contribute to chemotactic activity in the synovial fluid of patients with RA. The CCR5 density on T cell surface is constant over time for a given individual but varies drastically from one individual to another; this may represent a factor determining the intensity of joint inflammation in the course of RA 42 . Leukocytes, including neutrophils, macrophages and fibroblasts, are the primary source of cytokines. The synovial macrophages and fibroblasts produce a plethora of proinflammatory cytokines, including ILs, TNFs and GM-CSF and other cytokines and chemokines 43 . Activated neutrophils are reportedly a source of leukotriens and PGs, which synthesize IL-1, IL-1RA, IL-6, IL-12 and TNF-a. These cytokines can subsequently activate neutrophils and other cells 44 . In our study, these inflammatory mediators correlated with CD11b and also knee circumference. The source of these proinflammatory mediators appears to be infiltrating inflammatory cells, and the level of cellular infiltration strongly correlated with inflammatory mediator production.
Granulocytes, including neutrophils, eosinophils and basophils, are innate immune cells containing specialized granules; they provide the first line of immune defense. Neutrophils in particular predominate in early cellular infiltrate into the inflammatory sites and act via phagocytosis. Monocytes and macrophages destroy microbes later in the innate immune response. In the present study, MPO-positive neutrophils and Iba1-positive monocytes/macrophages were present in the inflamed synovium. MPO is the most prevalent protein in mature neutrophils and is a specific enzyme responsible for the production of highly reactive hypochlorous acid, chloride gas and chlorinated peptides, which act as a cytotoxic triad resulting cell death. MPO binds to the macrophage mannose receptor (MMR) and induces secretion of proinflammatory cytokines 45 . MPO may be present in the synovial fluid of patients of OA 46 and RA 47 . In the present study, MPO activity in CFA-induced synovitis peaked 3 days after induction, but was almost completely resolved by day 5. This suggested that neutrophils, which survive 2e3 days, are no longer present. LIUS decreased the MPO activity in the arthritic synovium.
Iba1, ionized calcium binding adaptor molecule 1, is a calcium binding protein whose expression is restricting to macrophage/ microglia 48 . Iba1 is localized in the cytoplasm and nucleus, however in the activated state Iba1 colocalized with F-action in membrane ruffles during phagocytosis 49 . In this study we demonstrated Iba1 immunoreactivity in the synovium. The immunoreactivity of MPO and Iba1 was not overlapped. In the sham control, Iba1 stained a few spindle-shaped cells; however, CFA-induced synovitis showed increased Iba1 staining, which represented membrane ruffling and increased phagocytosis. At day 3, MPO-positive neutrophils were present in the core and Iba1positive cells surrounded the core. Later, MPO-positive cells nearly disappeared with only a few positive cells remaining. The core was populated by Iba1-positive cells after 5 days. Therefore, neutrophils first infiltrate the inflamed synovium and release MPO which induces either a cytotoxic effect on infected cells or proinflammatory cytokine secretion by macrophages. Activated macrophages then enhance their phagocytic function by increasing Iba1 expression; this is followed by resolution of the inflammatory process. LIUS treatment markedly reduced leukocytes infiltration in the synovium and also attenuated hyperplasia. Therefore, the antiinflammatory effect of LIUS is closely related to modulation of infiltrating inflammatory cells.
